High Serum Levels of Matrix Metalloproteinase-9 and Matrix Metalloproteinase-1 Are Associated with Rapid Progression in Patients with Metastatic Melanoma
Nikkola, Johanna, Vihinen, Pia, Vuoristo, Meri-Sisko, Kellokumpu-Lehtinen, Pirkko, Kähäri, Veli-Matti, Pyrhönen, Seppo
Published in Clinical cancer research (15.07.2005)
Published in Clinical cancer research (15.07.2005)
Get full text
Journal Article
Detection of melanoma‐derived cancer‐testis antigen CT16 in patient sera by a novel immunoassay
Rappu, Pekka, Nylund, Camilla, Ristiniemi, Noora, Kulpakko, Janne, Vihinen, Pia, Hernberg, Micaela, Mirtti, Tuomas, Alanen, Kalle, Kallajoki, Markku, Vuoristo, Meri‐Sisko, Pyrhönen, Seppo, Heino, Jyrki
Published in International journal of cancer (15.05.2011)
Published in International journal of cancer (15.05.2011)
Get full text
Journal Article
ECCO essential requirements for quality cancer care: Melanoma
Wouters, Michel W., Michielin, Olivier, Bastiaannet, Esther, Beishon, Marc, Catalano, Orlando, del Marmol, Veronique, Delgado-Bolton, Roberto, Dendale, Rémi, Trill, Maria Die, Ferrari, Andrea, Forsea, Ana-Maria, Kreckel, Hannelore, Lövey, József, Luyten, Gre, Massi, Daniela, Mohr, Peter, Oberst, Simon, Pereira, Philippe, Prata, João Paulo Paiva, Rutkowski, Piotr, Saarto, Tiina, Sheth, Sapna, Spurrier-Bernard, Gilly, Vuoristo, Meri-Sisko, Costa, Alberto, Naredi, Peter
Published in Critical reviews in oncology/hematology (01.02.2018)
Published in Critical reviews in oncology/hematology (01.02.2018)
Get full text
Journal Article
Circulating tumor DNA is a prognostic biomarker in metastatic melanoma patients treated with chemoimmunotherapy and BRAF inhibitor
Mattila, Kalle E., Mäkelä, Siru, Kytölä, Soili, Andersson, Emma, Vihinen, Pia, Ramadan, Susan, Skyttä, Tanja, Tiainen, Leena, Vuoristo, Meri-Sisko, Tyynelä-Korhonen, Kristiina, Koivunen, Jussi, Kohtamäki, Laura, Aittomäki, Kristiina, Hernberg, Micaela
Published in Acta oncologica (03.10.2022)
Published in Acta oncologica (03.10.2022)
Get full text
Journal Article
Combination chemotherapy with temozolomide, lomustine, vincristine and interferon-alpha (TOL-IFN) plus vemurafenib or TOL-IFN as first-line treatment for patients with advanced melanoma
Mattila, Kalle E., Vihinen, Pia, Ramadan, Susan, Skyttä, Tanja, Tiainen, Leena, Vuoristo, Meri-Sisko, Tyynelä-Korhonen, Kristiina, Koivunen, Jussi, Kohtamäki, Laura, Mäkelä, Siru, Hernberg, Micaela
Published in Acta oncologica (03.03.2020)
Published in Acta oncologica (03.03.2020)
Get full text
Journal Article
Serum angiogenin levels predict treatment response in patients with stage IV melanoma
Vihinen, Pia, Kallioinen, Minna, Vuoristo, Meri-Sisko, Ivaska, Johanna, Syrjänen, Kari J, Hahka-Kemppinen, Marjo, Kellokumpu-Lehtinen, Pirkko-Liisa, Pyrhönen, Seppo O
Published in Clinical & experimental metastasis (01.11.2007)
Published in Clinical & experimental metastasis (01.11.2007)
Get full text
Journal Article
Circulating levels of VEGFR-1 and VEGFR-2 in patients with metastatic melanoma treated with chemoimmunotherapy alone or combined with bevacizumab
Vihinen, Pia P, Ramadan, Susan, Vuoristo, Meri-Sisko, Hernberg, Micaela, Tyynelä-Korhonen, Kristiina, Skyttä, Tanja, Koskivuo, Ilkka, Kellokumpu-Lehtinen, Pirkko-Liisa, Syrjänen, Kari, Pyrhönen, Seppo
Published in Melanoma research (01.10.2011)
Published in Melanoma research (01.10.2011)
Get more information
Journal Article
Randomized trial of dacarbazine versus bleomycin, vincristine, lomustine and dacarbazine (BOLD) chemotherapy combined with natural or recombinant interferon-alpha in patients with advanced melanoma
Vuoristo, Meri-Sisko, Hahka-Kemppinen, Marjo, Parvinen, Leena-Maija, Pyrhönen, Seppo, Seppä, Hanna, Korpela, Merja, Kellokumpu-Lehtinen, Pirkko
Published in Melanoma research (01.08.2005)
Published in Melanoma research (01.08.2005)
Get more information
Journal Article
Serum Matrix Metalloproteinase-2 as a Prognostic Marker in Advanced Cutaneous Melanoma
VUORISTO, Meri-Sisko, KELLOKUMPU-LEHTINEN, Pirkko, PARVINEN, Leena-Maija, HAHKA-KEMPPINEN, Marjo, KORPELA, Merja, KUMPULAINEN, Eero, LAINE, Seppo
Published in Acta oncologica (2000)
Published in Acta oncologica (2000)
Get full text
Journal Article
Conference Proceeding
Intermittent interferon and polychemotherapy in metastatic melanoma
Vuoristo, M S, Gröhn, P, Kellokumpu-Lehtinen, P, Kumpulainen, E, Turunen, M, Korpela, M, Joensuu, H, Tiusanen, K, Nevantaus, A
Published in Journal of cancer research and clinical oncology (01.03.1995)
Published in Journal of cancer research and clinical oncology (01.03.1995)
Get more information
Journal Article
A phase II trial of bevacizumab with dacarbazine and daily low-dose interferon-alpha2a as first line treatment in metastatic melanoma
Vihinen, Pia P, Hernberg, Micaela, Vuoristo, Meri-Sisko, Tyynelä, Kristiina, Laukka, Marjut, Lundin, Johan, Ivaska, Johanna, Pyrhönen, Seppo
Published in Melanoma research (01.08.2010)
Published in Melanoma research (01.08.2010)
Get more information
Journal Article
Serum levels of interleukins 2, 6 and 8, soluble interleukin-2 receptor and intercellular adhesion molecule-1 during treatment with interleukin-2 plus interferon-alfa
Vuoristo, M S, Kellokumpu-Lehtinen, P, Laine, S, Soppi, E
Published in Immunopharmacology and immunotoxicology (01.08.1996)
Published in Immunopharmacology and immunotoxicology (01.08.1996)
Get more information
Journal Article